Evidence map›Paper›PMID 31223651›Full record

ArticleScience advances2019

AFM-STED correlative nanoscopy reveals a dark side in fluorescence microscopy imaging.

Michela Cosentino, Claudio Canale, Paolo Bianchini, Alberto Diaspro

Abstract read
In one paragraph

Article in Science advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Expanding the microbiologist toolboxMicrobiology spectrum · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. AFM-Based Correlative Microscopy Illuminates Human Pathogens.Frontiers in cellular and infection microbiology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michela CosentinoDepartment of Nanophysics, Istituto Italiano di Tecnologia, Genova, Italy.ORCID 0000-0003-1495-7586
Claudio CanaleDepartment of Nanophysics, Istituto Italiano di Tecnologia, Genova, Italy.ORCID 0000-0002-7582-6849
Paolo BianchiniDepartment of Nanophysics, Istituto Italiano di Tecnologia, Genova, Italy.ORCID 0000-0001-6457-751X
Alberto DiasproDepartment of Nanophysics, Istituto Italiano di Tecnologia, Genova, Italy.ORCID 0000-0002-4916-5928

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is known that the presence of fluorophores can influence the dynamics of molecular processes. Despite this, an affordable technique to control the fluorophore distribution within the sample, as well as the rise of unpredictable anomalous processes induced by the fluorophore itself, is missing. We coupled a stimulated emission depletion (STED) microscope with an atomic force microscope to investigate the formation of amyloid aggregates. In particular, we studied the in vitro aggregation of insulin and two alloforms of β amyloid peptides. We followed standard methods to induce the aggregation and to label the molecules at different dye-to-protein ratios. Only a fraction of the fibrillar aggregates was displayed in STED images, indicating that the labeled molecules did not participate indistinctly to the aggregation process. This finding demonstrates that labeled molecules follow only selected pathways of aggregation, among the multiple that are present in the aggregation reaction.

Indexed as

AmyloidAmyloid beta-PeptidesAnimalsCattleEquipment DesignFluorescent DyesMicroscopy, FluorescenceSpectrometry, X-Ray EmissionAmyloidAmyloid beta-PeptidesFluorescent Dyes

Identifiers

PMID31223651
PMCPMC6584704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.